Literature DB >> 31219798

Association of lipid profile and BMI Z-score in southern Iranian children and adolescents.

Ashkan Habib1, Mohadeseh Molayemat1, Asadollah Habib2.   

Abstract

Background Heart disease has been the leading cause of death for decades in the US population. Dyslipidemia is the most important risk factor for cardiovascular disease (CVD), and it often starts during childhood. Methods This cross-sectional study was performed in a growth assessment clinic in the city of Shiraz to determine the relation between body mass index (BMI) and dyslipidemia among children and teenagers aged 2-18 years. Nine hundred and eighty-nine children including 422 boys and 567 girls were selected. Results Adjusted for age and gender, total cholesterol (TC) (r = 0.172, p = 0.000), low-density lipoprotein cholesterol (LDL-c) (r = 0.176, p = 0.000), non-high-density lipoprotein cholesterol (non-HDL-c) (r = 0.227, p = 0.000) and triglycerides (TG) (r = 0.253, p = 0.000) showed a significant positive correlation with BMI Z-score, and HDL-c showed a significant negative correlation with BMI Z-score (r = -0.131, p = 0.000). Adjusted for age and gender, overweight and obese children were 1.882 times more likely to have high TC levels (p = 0.009), 2.236 times more likely to have high non-HDL-c levels (p = 0.000) and 3.176 times more likely to have high TG levels (p = 0.000) in comparison with children who had a healthy weight. Obese children had the highest percentage of isolated TG dyslipidemia (23.1%) and underweight children had the highest percentage of isolated HDL dyslipidemia (15.6%). Conclusions There is a strong link between atherosclerotic cardiovascular disease (ASCVD) and the level of blood lipids and between blood lipids and BMI Z-score. The first step in preventing ASCVD is the reduction of blood lipids, preventing weight gain and loss of extra weight.

Entities:  

Keywords:  BMI; BMI Z-score; Iran; children; dyslipidemia

Mesh:

Substances:

Year:  2019        PMID: 31219798     DOI: 10.1515/jpem-2019-0002

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  2 in total

1.  Efficacy of Dapagliflozin Combined with Lifestyle Intervention in Obesity Control.

Authors:  Wenhui Dai; Qiaolin Peng
Journal:  Comput Math Methods Med       Date:  2022-05-13       Impact factor: 2.809

2.  Trends in Serum Lipid Profiles Among Korean Adolescents, 2007-2018.

Authors:  Da-Young Jeong; Shin-Hye Kim; Moon Young Seo; Sin Young Kang; Mi Jung Park
Journal:  Diabetes Metab Syndr Obes       Date:  2021-10-07       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.